Biobehavioral Risk Factors for Persistent Pain following Total Knee Arthroplasty

全膝关节置换术后持续疼痛的生物行为危险因素

基本信息

  • 批准号:
    8101280
  • 负责人:
  • 金额:
    $ 66.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Degenerative joint disease, particularly knee osteoarthritis (OA), is one of the most prevalent and disabling chronic pain conditions and is projected to increase sharply as the U.S. population ages. Projections also indicate that the annual number of total knee replacements, the treatment of choice for end-stage knee OA, will increase five- to ten-fold in the U.S. over the next several decades. While the outcomes following total knee arthroplasty are generally good, a substantial minority of patients continue to experience significant long-term pain and disability after surgery. These individual differences in the trajectory of pain and function after knee replacement are minimally related to findings from physical examination and imaging procedures. Our group has identified several potentially important variables that are likely to play a role in shaping long-term pain outcomes, though there are few published studies in patients with knee OA. The proposed 2-site prospective cohort project will carefully evaluate and follow a sample of patients undergoing total knee replacement. Knee OA patients will be assessed pre-surgically with a battery of psychophysical pain testing procedures, multimodal evaluation of sleep quality, continuity, and architecture, questionnaires regarding psychological function, and physiological sampling (e.g., blood and saliva samples). Outcomes such as pain, functioning, and analgesic usage will be evaluated through 12-month follow-up. These data will allow us to model the unique and combined impact of these classes of "risk factor" variables. Collectively, the identification of factors associated with the development and maintenance of persistent pain and pain-related disability following joint replacement has important practical implications for selection of surgical patients and for management of post-operative pain, as well as theoretical importance in understanding the sources of individual differences in pain-related outcomes. PUBLIC HEALTH RELEVANCE: Chronic pain is a critical national and international health problem, making the identification of groups at high risk for the development or persistence of chronic pain an increasingly important area of investigation. This project seeks to identify risk factors for persistent pain and physical disability following total knee replacement, a surgical procedure projected to increase five- to ten-fold in the U.S. over the next several decades. Collectively, the identification of factors associated with the development and maintenance of persistent pain and pain-related disability following joint replacement has important practical implications for the selection of surgical patients, for the management of post-operative pain, and for understanding the sources of individual differences in pain-related outcomes.
描述(由申请人提供):退行性关节疾病,特别是膝关节骨关节炎(OA),是最普遍和致残的慢性疼痛疾病之一,预计将随着美国人口老龄化而急剧增加。预测还表明,全膝关节置换术(终末期膝关节OA的首选治疗)的年度数量在未来几十年内将在美国增加5至10倍。虽然全膝关节置换术后的结局通常良好,但仍有相当一部分患者在手术后继续经历显著的长期疼痛和残疾。膝关节置换术后疼痛和功能轨迹的这些个体差异与体格检查和影像学检查结果的相关性极小。我们的小组已经确定了几个潜在的重要变量,这些变量可能在塑造长期疼痛结局方面发挥作用,尽管在膝关节OA患者中发表的研究很少。拟定的2中心前瞻性队列项目将仔细评价并随访接受全膝关节置换术的患者样本。膝关节OA患者将在术前进行评估,包括一系列心理物理疼痛测试程序,睡眠质量、连续性和结构的多模式评价,关于心理功能的问卷调查和生理采样(例如,血液和唾液样本)。将通过12个月随访评价疼痛、功能和镇痛剂使用等结局。这些数据将使我们能够对这些类别的“风险因素”变量的独特和综合影响进行建模。总的来说,识别与关节置换术后持续性疼痛和疼痛相关残疾的发展和维持相关的因素,对手术患者的选择和术后疼痛的管理具有重要的实际意义,以及在理解疼痛相关结局的个体差异来源方面的理论重要性。 公共卫生相关性:慢性疼痛是一个严重的国家和国际健康问题,使识别慢性疼痛发展或持续的高风险群体成为越来越重要的调查领域。该项目旨在确定全膝关节置换术后持续疼痛和身体残疾的风险因素,预计在未来几十年内,全膝关节置换术在美国将增加五到十倍。总的来说,识别与关节置换术后持续性疼痛和疼痛相关残疾的发展和维持相关的因素,对于手术患者的选择,术后疼痛的管理以及理解疼痛相关结局的个体差异的来源具有重要的实际意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT R EDWARDS其他文献

ROBERT R EDWARDS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT R EDWARDS', 18)}}的其他基金

Sensory Phenotyping to Enhance Neuropathic Pain Drug Development
感觉表型增强神经病理性疼痛药物的开发
  • 批准号:
    10724809
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Impact of Theory of Mind Training on Brain-to-Brain Patient-Clinician Concordance
心理理论训练对脑-脑患者-临床医生一致性的影响
  • 批准号:
    10544363
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Mentorship in precision pain medicine via EPPIC-NET
通过 EPPIC-NET 进行精准疼痛医学指导
  • 批准号:
    10426787
  • 财政年份:
    2021
  • 资助金额:
    $ 66.57万
  • 项目类别:
Clinical Coordinating Center for the Health Initiative in Early Phase Pain Investigation Clinical Network
早期疼痛调查临床网络健康倡议临床协调中心
  • 批准号:
    10246465
  • 财政年份:
    2019
  • 资助金额:
    $ 66.57万
  • 项目类别:
Clinical Coordinating Center for the Health Initiative in Early Phase Pain Investigation Clinical Network
早期疼痛调查临床网络健康倡议临床协调中心
  • 批准号:
    10703234
  • 财政年份:
    2019
  • 资助金额:
    $ 66.57万
  • 项目类别:
Clinical Coordinating Center for the Health Initiative in Early Phase Pain Investigation Clinical Network
早期疼痛调查临床网络健康倡议临床协调中心
  • 批准号:
    10480912
  • 财政年份:
    2019
  • 资助金额:
    $ 66.57万
  • 项目类别:
Opioid-induced change in pain sensitivity and modulation: Links to opioid misuse
阿片类药物引起的疼痛敏感性和调节变化:与阿片类药物滥用的联系
  • 批准号:
    9035522
  • 财政年份:
    2016
  • 资助金额:
    $ 66.57万
  • 项目类别:
Brain Mechanisms Underlying CBT-Related Reductions in Fibromyalgia
CBT 相关减少纤维肌痛的大脑机制
  • 批准号:
    9071290
  • 财政年份:
    2014
  • 资助金额:
    $ 66.57万
  • 项目类别:
Brain Mechanisms Underlying CBT-Related Reductions in Fibromyalgia
CBT 相关减少纤维肌痛的大脑机制
  • 批准号:
    8631674
  • 财政年份:
    2014
  • 资助金额:
    $ 66.57万
  • 项目类别:
Young Investigator Travel Support for 2013 APS Annual Scientific Meeting
2013 年 APS 年度科学会议年轻研究者旅行支持
  • 批准号:
    8529153
  • 财政年份:
    2013
  • 资助金额:
    $ 66.57万
  • 项目类别:

相似海外基金

Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
  • 批准号:
    10641500
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
  • 批准号:
    10485593
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
  • 批准号:
    10728526
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
  • 批准号:
    10621646
  • 财政年份:
    2023
  • 资助金额:
    $ 66.57万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10425794
  • 财政年份:
    2022
  • 资助金额:
    $ 66.57万
  • 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
  • 批准号:
    22K19602
  • 财政年份:
    2022
  • 资助金额:
    $ 66.57万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
  • 批准号:
    10512672
  • 财政年份:
    2022
  • 资助金额:
    $ 66.57万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10721752
  • 财政年份:
    2022
  • 资助金额:
    $ 66.57万
  • 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
  • 批准号:
    10821681
  • 财政年份:
    2022
  • 资助金额:
    $ 66.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了